Logo image of AIRS

AIRSCULPT TECHNOLOGIES INC (AIRS) Stock Fundamental Analysis

NASDAQ:AIRS - Nasdaq - US0094961002 - Common Stock - Currency: USD

5.325  -0.5 (-8.66%)

After market: 5.25 -0.08 (-1.41%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AIRS. AIRS was compared to 108 industry peers in the Health Care Providers & Services industry. AIRS may be in some trouble as it scores bad on both profitability and health. AIRS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

AIRS had negative earnings in the past year.
AIRS had a positive operating cash flow in the past year.
In multiple years AIRS reported negative net income over the last 5 years.
In the past 5 years AIRS always reported a positive cash flow from operatings.
AIRS Yearly Net Income VS EBIT VS OCF VS FCFAIRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 10M -10M 20M

1.2 Ratios

AIRS's Return On Assets of -3.74% is in line compared to the rest of the industry. AIRS outperforms 40.19% of its industry peers.
AIRS has a Return On Equity of -9.44%. This is comparable to the rest of the industry: AIRS outperforms 43.93% of its industry peers.
AIRS has a Return On Invested Capital of 1.60%. This is comparable to the rest of the industry: AIRS outperforms 42.99% of its industry peers.
Industry RankSector Rank
ROA -3.74%
ROE -9.44%
ROIC 1.6%
ROA(3y)-1.41%
ROA(5y)-0.26%
ROE(3y)-4.47%
ROE(5y)-1.82%
ROIC(3y)N/A
ROIC(5y)N/A
AIRS Yearly ROA, ROE, ROICAIRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 10 -10 -20

1.3 Margins

AIRS's Operating Margin of 1.96% is in line compared to the rest of the industry. AIRS outperforms 49.53% of its industry peers.
In the last couple of years the Operating Margin of AIRS has declined.
With an excellent Gross Margin value of 64.98%, AIRS belongs to the best of the industry, outperforming 85.98% of the companies in the same industry.
AIRS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.96%
PM (TTM) N/A
GM 64.98%
OM growth 3Y-33.27%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.91%
GM growth 5YN/A
AIRS Yearly Profit, Operating, Gross MarginsAIRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

AIRS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
AIRS has more shares outstanding than it did 1 year ago.
The debt/assets ratio for AIRS has been reduced compared to a year ago.
AIRS Yearly Shares OutstandingAIRS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
AIRS Yearly Total Debt VS Total AssetsAIRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

AIRS has an Altman-Z score of 2.21. This is not the best score and indicates that AIRS is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.21, AIRS perfoms like the industry average, outperforming 53.27% of the companies in the same industry.
The Debt to FCF ratio of AIRS is 58.70, which is on the high side as it means it would take AIRS, 58.70 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AIRS (58.70) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.80 indicates that AIRS is somewhat dependend on debt financing.
AIRS's Debt to Equity ratio of 0.80 is in line compared to the rest of the industry. AIRS outperforms 40.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 58.7
Altman-Z 2.21
ROIC/WACC0.18
WACC8.78%
AIRS Yearly LT Debt VS Equity VS FCFAIRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.51 indicates that AIRS may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.51, AIRS is doing worse than 92.52% of the companies in the same industry.
AIRS has a Quick Ratio of 0.51. This is a bad value and indicates that AIRS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.51, AIRS is doing worse than 90.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.51
AIRS Yearly Current Assets VS Current LiabilitesAIRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

4

3. Growth

3.1 Past

AIRS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.69%.
AIRS shows a decrease in Revenue. In the last year, the revenue decreased by -0.12%.
Measured over the past years, AIRS shows a very strong growth in Revenue. The Revenue has been growing by 46.12% on average per year.
EPS 1Y (TTM)-7.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-233.33%
Revenue 1Y (TTM)-0.12%
Revenue growth 3Y46.12%
Revenue growth 5YN/A
Sales Q2Q%-9.07%

3.2 Future

Based on estimates for the next years, AIRS will show a very strong growth in Earnings Per Share. The EPS will grow by 75.67% on average per year.
The Revenue is expected to grow by 6.69% on average over the next years.
EPS Next Y6.5%
EPS Next 2Y41.42%
EPS Next 3Y54.96%
EPS Next 5Y75.67%
Revenue Next Year-6.03%
Revenue Next 2Y1.29%
Revenue Next 3Y4.35%
Revenue Next 5Y6.69%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AIRS Yearly Revenue VS EstimatesAIRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
AIRS Yearly EPS VS EstimatesAIRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 0.6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

AIRS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AIRS Price Earnings VS Forward Price EarningsAIRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as AIRS.
AIRS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 257.92
EV/EBITDA 24.54
AIRS Per share dataAIRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

AIRS's earnings are expected to grow with 54.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y54.96%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AIRS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AIRSCULPT TECHNOLOGIES INC

NASDAQ:AIRS (2/21/2025, 8:00:40 PM)

After market: 5.25 -0.08 (-1.41%)

5.325

-0.5 (-8.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-08 2024-11-08/bmo
Earnings (Next)03-07 2025-03-07/amc
Inst Owners23.34%
Inst Owner Change-99.57%
Ins Owners26.92%
Ins Owner Change0.01%
Market Cap308.21M
Analysts74.55
Price Target6.97 (30.89%)
Short Float %22.03%
Short Ratio12.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)N/A
DP-2.43%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-170.97%
Min EPS beat(2)-245.86%
Max EPS beat(2)-96.08%
EPS beat(4)1
Avg EPS beat(4)-60.97%
Min EPS beat(4)-492.16%
Max EPS beat(4)590.2%
EPS beat(8)2
Avg EPS beat(8)-69.21%
EPS beat(12)3
Avg EPS beat(12)-124.83%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.78%
Min Revenue beat(2)-9.52%
Max Revenue beat(2)-0.03%
Revenue beat(4)0
Avg Revenue beat(4)-4.68%
Min Revenue beat(4)-9.52%
Max Revenue beat(4)-0.03%
Revenue beat(8)2
Avg Revenue beat(8)-1.92%
Revenue beat(12)5
Avg Revenue beat(12)-0.74%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.89%
PT rev (3m)74.47%
EPS NQ rev (1m)-51.13%
EPS NQ rev (3m)-181.25%
EPS NY rev (1m)-1.14%
EPS NY rev (3m)-193.32%
Revenue NQ rev (1m)-2.27%
Revenue NQ rev (3m)-23.75%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.36%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.63
P/FCF 257.92
P/OCF 22.83
P/B 3.73
P/tB N/A
EV/EBITDA 24.54
EPS(TTM)-0.14
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)0.02
FCFY0.39%
OCF(TTM)0.23
OCFY4.38%
SpS3.26
BVpS1.43
TBVpS-0.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.74%
ROE -9.44%
ROCE 2.03%
ROIC 1.6%
ROICexc 1.66%
ROICexgc 5.59%
OM 1.96%
PM (TTM) N/A
GM 64.98%
FCFM 0.63%
ROA(3y)-1.41%
ROA(5y)-0.26%
ROE(3y)-4.47%
ROE(5y)-1.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-29.15%
ROICexcg growth 5YN/A
ROICexc growth 3Y-5.14%
ROICexc growth 5YN/A
OM growth 3Y-33.27%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.91%
GM growth 5YN/A
F-Score4
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 58.7
Debt/EBITDA 4.38
Cap/Depr 107.34%
Cap/Sales 6.52%
Interest Coverage 0.62
Cash Conversion 88.98%
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.51
Altman-Z 2.21
F-Score4
WACC8.78%
ROIC/WACC0.18
Cap/Depr(3y)121.64%
Cap/Depr(5y)103.97%
Cap/Sales(3y)6.02%
Cap/Sales(5y)6.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-233.33%
EPS Next Y6.5%
EPS Next 2Y41.42%
EPS Next 3Y54.96%
EPS Next 5Y75.67%
Revenue 1Y (TTM)-0.12%
Revenue growth 3Y46.12%
Revenue growth 5YN/A
Sales Q2Q%-9.07%
Revenue Next Year-6.03%
Revenue Next 2Y1.29%
Revenue Next 3Y4.35%
Revenue Next 5Y6.69%
EBIT growth 1Y33.42%
EBIT growth 3Y-2.49%
EBIT growth 5YN/A
EBIT Next Year104.51%
EBIT Next 3Y49.43%
EBIT Next 5Y52.22%
FCF growth 1Y217.16%
FCF growth 3Y10.98%
FCF growth 5YN/A
OCF growth 1Y11.6%
OCF growth 3Y19.72%
OCF growth 5YN/A